TY - JOUR
T1 - Study on caspase-induced mitochondrial dysfunction by anticancer drugs
AU - Tao, Zhimin
AU - Morrow, Matthew P.
AU - Penefsky, Harvey S.
AU - Goodisman, Jerry
AU - Souid, Abdul Kader
N1 - Publisher Copyright:
©2007 Bentham Science Publishers Ltd.
PY - 2007
Y1 - 2007
N2 - Apoptosis, induced in tumors by anticancer agents, is characterized by caspase activation, impaired cellular respiration and decreased cellular ATP. Respiration in Jurkat and HL-60 cells treated with doxorubicin, dactinomycin or platinum drugs is measured using a Pd(II) phosphor that monitors [O2 ] in cell suspensions as a function of time. Cellular ATP is determined using the luciferin-luciferase bioluminescence system. Intracellular caspase activation is measured by allowing caspases to cleave Ac-DEVD-AFC to the fluorescent AFC, which is detected on HPLC. Comparing the ways in which respiration, ATP level, and caspase activity vary with time points up differences between the mechanisms of actions of doxorubicin, dactinomycin and the platinum compounds. These methods accurately determine the sensitivity of tumors to anticancer drugs.
AB - Apoptosis, induced in tumors by anticancer agents, is characterized by caspase activation, impaired cellular respiration and decreased cellular ATP. Respiration in Jurkat and HL-60 cells treated with doxorubicin, dactinomycin or platinum drugs is measured using a Pd(II) phosphor that monitors [O2 ] in cell suspensions as a function of time. Cellular ATP is determined using the luciferin-luciferase bioluminescence system. Intracellular caspase activation is measured by allowing caspases to cleave Ac-DEVD-AFC to the fluorescent AFC, which is detected on HPLC. Comparing the ways in which respiration, ATP level, and caspase activity vary with time points up differences between the mechanisms of actions of doxorubicin, dactinomycin and the platinum compounds. These methods accurately determine the sensitivity of tumors to anticancer drugs.
UR - http://www.scopus.com/inward/record.url?scp=49049120929&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=49049120929&partnerID=8YFLogxK
U2 - 10.2174/157488507781695621
DO - 10.2174/157488507781695621
M3 - Article
AN - SCOPUS:49049120929
SN - 1574-8855
VL - 2
SP - 233
EP - 235
JO - Current Drug Therapy
JF - Current Drug Therapy
IS - 3
ER -